Insights & News

Logical Biological, biospecimen and critical raw material leader, and Bcell Design, pioneers in transgenic monoclonal antibody technology, today announced a long term strategic partnership to deliver engineered disease state materials for diagnostic and research markets.

Logical Biological, biospecimen and critical material experts, today announced the launch of a new sister company, Logical Antigen, focused on rapid and customised delivery of high-quality antigens and biologicals, for research and manufacturing of diagnostic products.

High-titre biological materials play a vital role in the development and manufacturing of in vitro diagnostic (IVD) controls and calibrators. However, sourcing bulk high-titre disease state materials presents significant challenges for Quality Control and Calibrator Manufacturers. These obstacles impact downstream processes for IVD companies, and more importantly, the patients who awaiting testing, diagnosis, and treatment.

When it comes to manufacturing quality controls (QCs), choosing the right raw material is essential. With factors like supply sustainability, cost, and performance to be considered, how do you decide whether a native or synthetic biological raw material is best?

Lot-to-lot consistency ensures that QC manufacturers can maintain consistent analyte target concentrations in their products, facilitating smooth validation processes and ensuring regulatory compliance. This article explores the key considerations for QC manufacturers in achieving lot-to-lot consistency when utilising bulk biological raw materials.

Calprotectin is a heterodimer protein expressed by leucocytes and used as a biomarker for Inflammatory Bowel Disease (IBD).

We are proud to announce the appointment of Stephane Argivier as our new Chief Executive Officer, effective from 1st September 2024. Stephane Argivier will lead the next stage in the company’s expansion.

We are proud to announce that Logical Biological has been honoured with a King’s Award for Enterprise. This prestigious award recognises Logical Biological’s excellence in International Trade for Outstanding Short-Term Growth in overseas sales over the last three years (2020-2022).

Sexually Transmitted Infections (STIs) continue to be a significant global health concern, affecting millions of people each year, irrespective of geographical location or economic status. While the spotlight often falls on diseases like HIV and syphilis due to their severe consequences and historical significance, other STIs such as chlamydia, gonorrhoea, and human papillomavirus (HPV) also pose substantial threats to public health worldwide.